The indigenous microbiota impact mucosal, as well as systemic, immune responses, but whether the microbiota are involved in stressor-induced immunomodulation has not been thoroughly tested. A well characterized murine stressor, called social disruption (SDR), was used to study whether the microbiota are involved in stressor-induced enhancement of macrophage reactivity. Exposure to the SDR Stressor enhanced the ability of splenic macrophages to produce microbicidal mediators (e.g., inducible nitric oxide synthase (iNOS), superoxide anion, and peroxynitrite) and to kill target Escherichia coli. Exposure to the SDR Stressor also increased cytokine production by LPS-stimulated splenic macrophages. These effects, however, were impacted by the microbiota. Microbicidal activity and cytokine mRNA in splenic macrophages from Swiss Webster germfree mice that lack any commensal microbiota were not enhanced by exposure to the SDR Stressor. However, when germfree mice were conventionalized by colonizing them with microbiota from CD1 conventional donor mice, exposure to the SDR Stressor again increased microbicidal activity and cytokine mRNA. In follow-up experiments, immunocompetent conventional CD1 mice were treated with a cocktail of antibiotics to disrupt the intestinal microbiota. While exposure to the SDR Stressor-enhanced splenic macrophage microbicidal activity and cytokine production in vehicle-treated mice, treatment with antibiotics attenuated the SDR Stressor-induced increases in splenic macrophage reactivity. Treatment with antibiotics also prevented the stressor-induced increase in circulating levels of bacterial peptidoglycan, suggesting that translocation of microbiota-derived peptidoglycan into the body primes the innate immune system for enhanced activity. This study demonstrates that the microbiota play a crucial role in stressor-induced immunoenhancement.
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Introduction
The mammalian body is populated by immense and complex consortia of microbes generally referred to as the microbiota. Bacteria are by far the most predominant and beneficial members of the microbiota, but some archaea and eukarya can also be found residing on the body (O'Hara and Shanahan, 2006) . In the healthy host, the vast majority of the microbiota are found within the lower sections of the gastrointestinal tract (i.e., distal ileum and colon) where they reside in stable climax communities as a result of ecological successions involving the selection of microbes best adapted for their given niche (Huffnagle, 2010) . Although these climax communities are relatively resistant to change (Allison and Martiny, 2008) , many factors, such as diet or antibiotic use, can cause transient alterations in community structure (Antonopoulos et al., 2009; Dethlefsen et al., 2008) . We have shown that exposure to experimental stressors, such as prolonged restraint (Bailey et al., 2010) as well as social disruption (SDR) (Bailey et al., 2011) , also impact the stability of the intestinal microbiota. For example, exposure to the SDR Stressor significantly changed the relative abundance of 7 out of the top 30 genera of bacteria residing as the microbiota (Bailey et al., 2011) . Whether these stressorinduced effects on the microbiota impact the health of the host is not yet known.
The microbiota are intimately associated with mucosal surfaces, and are well known to influence the development of the mucosal immune system. This is most evident in germfree mice, i.e., mice
